Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INTELLI-DESVENLAFAXINE - Health Canada Drug Approval Details

Approvals/Health Canada/INTELLI-DESVENLAFAXINE

Authorized

STANDARD

INTELLI-DESVENLAFAXINE

Intellipharmaceutics Corp🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 37eb1e3953b91c7d
Company: Intellipharmaceutics Corp
Type: Standard

Approval Details

Approval Id: 37eb1e3953b91c7d
Drug Approval Canada Name: INTELLI-DESVENLAFAXINE
Product Name: INTELLI-DESVENLAFAXINE
Status: Approved
Status Date: 2022-02-14
Din: 02469847
Drug Class: Human
Dosage Form: Tablet (Extended-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX23 DESVENLAFAXINE
Atc Name: n 06 ax 23
Aig Number: 0152509001
Company Name: Intellipharmaceutics Corp
Company Address: 30 Worcester Road, Toronto, Ontario, Canada, M9W 5X2
Company Detail Path: /organization/intellipharmaceutics-corp

Company Information

Pharmaceutical Company Name: Intellipharmaceutics Corp
Country Name: Canada
Province Name: Ontario
City Name: etobicoke,ontario,country_ca
Address: 30 Worcester Rd

Active Ingredients

DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

50 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

37eb1e3953b91c7d

Type

Standard

Back to Health Canada Approvals